Ozmosi | Synflorix Drug Profile

Product Description

Pneumococcal Vaccine (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01175083)

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: Intramuscular

FDA Designation: *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: GSK
Company Location: Europe
Company Founding Year: 2000
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Synflorix

Countries in Clinic: Finland, Poland

Active Clinical Trial Count: 1

Recent & Upcoming Milestones

Highest Development Phases

Phase 2: Pneumococcal Infections

Trial ID	Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success	Latest Trial Update Date	Data Updated
2023-505154-18-00	C4801002	P2	Completed	Pneumococcal Infections	2024-05-27		2025-05-02	Treatments

Recent News Events

Date	Type	Title
03/17/2025	News Article	Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
02/04/2025	News Article	Arcturus Therapeutics Announces Appointment of Moncef Slaoui, Ph.D., as Chair Designate
06/20/2024	News Article	Arcturus Therapeutics Appoints Moncef Slaoui, Ph.D., to Board of Directors
12/01/2023	PubMed	Otitis media at 6-monthly assessments of Australian First Nations children between ages 12-36 months: Findings from two randomised controlled trials of combined pneumococcal conjugate vaccines.
09/05/2023	News Article	Pneumococcal Vaccine Market Report, Size, Growth, Demand, Forecast 2023-28
07/01/2023	PubMed	Assessing Public Health Impact of Four Pediatric Pneumococcal Conjugate Vaccination Strategies in the Netherlands.
05/05/2023	PubMed	Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (Synflorix(TM) and Prevenar13(TM))) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian children.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions

Session Expiring Soon

Synflorix

Alternative Names: Synflorix, GSK-1024850A, GSK1024850A, GSK 1024850A, GSK-1024850, GSK1024850, GSK 1024850 Clinical Status: Active Latest Update: 2025-03-17 Latest Update Note: News Article